ID: ALA187177

Max Phase: Preclinical

Molecular Formula: C25H19FO5S

Molecular Weight: 450.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(-c2cc(-c3ccc(S(C)(=O)=O)cc3)c(-c3ccc(F)cc3)c(=O)o2)cc1

Standard InChI:  InChI=1S/C25H19FO5S/c1-30-20-11-5-17(6-12-20)23-15-22(16-7-13-21(14-8-16)32(2,28)29)24(25(27)31-23)18-3-9-19(26)10-4-18/h3-15H,1-2H3

Standard InChI Key:  PRKFAYYSPVLICT-UHFFFAOYSA-N

Associated Targets(non-human)

Prostaglandin G/H synthase (cyclooxygenase) 160 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclooxygenase-1 5266 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclooxygenase-2 1953 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 450.49Molecular Weight (Monoisotopic): 450.0937AlogP: 5.19#Rotatable Bonds: 5
Polar Surface Area: 73.58Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 4.05CX LogD: 4.05
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.42Np Likeness Score: -0.50

References

1. Rao PN, Uddin MJ, Knaus EE..  (2004)  Design, synthesis, and structure-activity relationship studies of 3,4,6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors.,  47  (16): [PMID:15267236] [10.1021/jm049939b]

Source